Communicable and Infectious Disease Emergencies

CHAPTER 19 Communicable and Infectious Disease Emergencies





I. GENERAL STRATEGY



A. Assessment




1. Primary and secondary assessment/resuscitation (see Chapter 1)


2. Focused assessment











3. Diagnostic procedures


































F. Age-Related Considerations




1. Pediatrics













2. Geriatric


















II. SPECIFIC COMMUNICABLE AND INFECTIOUS DISEASE EMERGENCIES



A. Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome


Human immunodeficiency virus (HIV) results from infection by a retrovirus. Acquired immunodeficiency syndrome (AIDS) is a life-threatening disease, which is the late stage of HIV infection and the addition of opportunistic infections. Transmission occurs by direct contact of a person’s blood or body secretions with the blood or body secretions of a person infected with HIV. Antibody seroconversion usually takes place within 45 days of exposure but may not occur for up to 6 months after infection. Acute HIV infection is characterized by a mononucleosis-like or other viral-like syndrome occurring 2 to 6 weeks after exposure. This is followed by a clinically asymptomatic period lasting months to years, during which time the virus replicates, mutates, and destroys the immune system. Then development of persistent generalized lymphadenopathy occurs, and finally the opportunistic diseases develop, including constitutional disorders, neurologic disorders, secondary infections, secondary cancers, and other infections such as pneumonitis. Development of these problems signals the beginning of AIDS. Currently, it is believed that all HIV infection will at some point result in AIDS. At present, the mean length of time between exposure to HIV and development of AIDS is about 10 years. The sooner treatment begins after infection, the better a person’s long-term survival will be.


HIV infection causes a defect in cell-mediated immunity and results in decreased resistance to other opportunistic infections. Specifically, it attacks the CD4 cell, which is the cornerstone of the immune system that identifies everyday infections and starts an immune response. All patients are profoundly immunodeficient at the onset of AIDS. There is aberration in the number and function of T lymphocytes, with a decrease in T-helper cells, B lymphocytes, and macrophages. Syphilis and drug-resistant TB frequently occur. Extrapulmonary TB is more common in HIV-infected patients, particularly TB affecting the meninges, bones, joints, and urinary tract. Opportunistic infections, commonly Pneumocystis carinii pneumonia, cytomegalovirus (CMV) infection, and Kaposi’s sarcoma, are the usual causes of death.




1. Assessment








2. Analysis: differential nursing diagnoses/collaborative problems






3. Planning and implementation/interventions




























4. Evaluation and ongoing monitoring (see Appendix B)







B. Diphtheria


Diphtheria is an acute, highly contagious disease caused by a gram-negative bacillus, Corynebacterium diphtheriae, which produces a systemic toxin and usually causes membranous nasopharyngitis or obstructive laryngotracheitis. Cutaneous lesions may also occur. Diphtheria is spread by airborne respiratory droplets or by direct contact with respiratory secretions or skin lesion exudate. The exotoxin of this rapidly progressive illness can result in widespread organ damage and complications, including myocarditis, thrombocytopenia, vocal cord paralysis, acute tubular necrosis, and an ascending paralysis similar to Guillain-Barré syndrome. Diphtheria is rare in the United States and seen most often in the South and the Pacific Northwest among urban and rural poor populations. It occurs in immunized as well as nonimmunized persons, and the severity of illness is directly related to immunization status. The only effective control of this disease is universal immunization. The incidence is greatest in fall and winter; transmission occurs by intimate contact, typically in crowded living conditions. The incubation period is 2 to 5 days. Treated illness is communicable for up to 4 days; untreated illness can be spread for up to 2 weeks. Occurrence of active disease does not confer immunity. Pseudomembranous inflammation develops on mucosal surfaces of the throat, which may lead to airway obstruction. Death usually results from respiratory (asphyxia) or cardiac (myocarditis) complications. Death is most common in the very young and elderly, usually within 3 or 4 days of the onset of illness.




1. Assessment








2. Analysis: differential nursing diagnosis/collaborative problems






3. Planning and implementation/interventions

























4. Evaluation and ongoing monitoring (see Appendix B)







C. Encephalitis


Encephalitis is a viral infection of the brain that causes an inflammatory response of brain tissue. It often coexists with meningitis and has a broad range of signs and symptoms, ranging from unrecognized mild cases to profound neurologic involvement. Most cases in North America are caused by arboviruses, herpes simplex virus (HSV) type 1, varicella-zoster virus (VZV), Epstein-Barr virus (EBV), and rabies. Transmission may be by animal bites (rabies) or may occur seasonally from vectors (e.g., mosquitoes, ticks, and midges carry arboviruses, Lyme disease, Rocky Mountain spotted fever, and so on). The more common human viruses are airborne and are transmitted via droplet or lesion exudate to the person, in whom replication takes place. The virus then enters the nervous system through the blood. In the brain, the virus enters the neuron, where it causes inflammation, neurologic dysfunction, and damage. Encephalitis occurs in all age groups, and mortality ranges from 5% to 10% from arbovirus infection to nearly 100% for rabies.




1. Assessment








2. Analysis: differential nursing diagnoses/collaborative problems





3. Planning and implementation/interventions
























4. Evaluation and ongoing monitoring (see Appendix B)









D. Hepatitis


Hepatitis is a viral syndrome involving the hepatic triad (bile duct, hepatic venule, and arteriole) and the central vein area. Cellular inflammation leads to disruption of the hepatic architecture. Types of hepatitis viruses are identified by letters and vary in incubation and duration periods. Hepatitis A virus (Table 19-1) is transmitted primarily through the fecal-oral route. It is found in serum and stool and is infectious 2 weeks before and 1 to 2 weeks after the appearance of jaundice. Hepatitis B virus (HBV) (see Table 19-1) is transmitted most commonly by IV drug use, sexual contact, and less frequently through blood transfusions since testing of the blood supply began. Hepatitis B surface antigen (HBsAg) appears early in the disease process. Hepatitis B e antigen (HBeAg), thought to be a degradation product of the hepatitis B core antigen (HBcAg), also appears about the same time. Antibodies are produced for each antigen. Persistence of core antibodies indicates chronic infection. Persistence of surface antibodies indicates immunity to reinfection. HBsAg in the serum without symptoms is indicative of a carrier state. Hepatitis C virus (see Table 19-1) is transmitted mostly through IV drug use and blood transfusions and is identified by the presence of antihepatitis C virus antibodies. As many as 50% of hepatitis C infections become chronic, and there is no immunity. Hepatitis C causes approximately 60% of hepatitis cases transmitted by blood transfusion. Hepatitis D is found only in patients with acute or chronic HBV infection and is transmitted most commonly by IV drug use and sexual contact. Hepatitis E is an endemic, enterically transmitted infection caused by eating or drinking contaminated food or water and is similar to hepatitis A. Patients with all forms of hepatitis present with the same clinical features; laboratory testing determines the specific origin. Hepatitis A usually resolves in 4 to 8 weeks and hepatitis E in 6 to 9 months. The remaining types can all continue in a chronic state, which may result in cirrhosis and liver cancer. At this time, there is no cure; however, treatments using interferons and ribavirin are showing success in management of the diseases.




Nov 8, 2016 | Posted by in NURSING | Comments Off on Communicable and Infectious Disease Emergencies

Full access? Get Clinical Tree

Get Clinical Tree app for offline access